New Born Screening

This solicitation seeks genetic newborn screening testing services for William Beaumont Army Medical Center at Fort Bliss, Texas. The Department of the Army Medical Command requires the contractor to provide testing for glucose-6-phosphate dehydrogenase deficiency, biotinidase deficiency, galactosemia, cystic fibrosis, congenital adrenal hyperplasia, congenital hypothyroidism, and hemoglobinopathies. The contractor must be CAP/CLIA accredited and FDA licensed to perform the required testing. The performance period is for a base year with two one-year options. Proposals are due by September 1, 2021.

The opportunity is set aside for total small business. The estimated annual testing volume is 1,200 tests for each condition. The contractor shall maintain necessary facilities, personnel, supplies, and a quality control program. Test results must be reported electronically within 72 hours of sample receipt. The place of performance is El Paso, Texas. The contractor is responsible for sample shipping and must resolve any result or sample discrepancies with the customer.